IntuitionLabs

AI Drug Discovery & Development Summit (Kisaco Research)

Oct 27-29|Boston Marriott Copley Place, Boston, MA|in-person
AI & Data

Conference Focus

AI in drug discovery and development (leading global event)

Overview

The AI Drug Discovery & Development Summit, organized by Kisaco Research, is a premier annual event focused on the integration of artificial intelligence and machine learning into the pharmaceutical R&D pipeline. It brings together global leaders to explore how AI can accelerate target identification, optimize lead discovery, and streamline clinical development. The summit is highly regarded for its focus on practical, actionable insights, bridging the gap between cutting-edge computational research and real-world drug development outcomes. This event stands out for its emphasis on cross-functional collaboration, bringing together data scientists, biologists, and clinical researchers. Attendees gain access to case studies from major pharma and innovative biotech firms, highlighting both the successes and the technical challenges of implementing AI. It is a critical forum for shaping the future of digital transformation in the life sciences sector.

Why Attend

Professionals should attend to gain a competitive edge by understanding the latest AI-driven methodologies that are reducing time-to-market for new therapies. The summit offers unparalleled networking with industry pioneers, providing opportunities to benchmark strategies and form strategic partnerships. Attendees will leave with a clearer roadmap for integrating AI tools into their own R&D workflows, ultimately driving efficiency and innovation in their drug discovery programs.

Key Topics & Sessions

  • AI-driven target identification and validation
  • Generative AI for de novo drug design
  • Predictive toxicology and safety modeling
  • AI in clinical trial design and patient stratification
  • Data quality, governance, and interoperability
  • Multi-omics data integration
  • AI-enabled protein structure prediction
  • Regulatory pathways for AI-developed drugs
  • Translational medicine and biomarker discovery
  • Scaling AI infrastructure in pharma

Who Should Attend

Chief Scientific OfficersHeads of Computational BiologyDirectors of Drug DiscoveryVP of AI/Machine LearningClinical Development LeadsBioinformatics ScientistsHeads of Digital Transformation

Conference History

Kisaco Research has established this summit as a leading fixture in the industry calendar. Over the years, it has grown significantly, mirroring the rapid adoption of AI in pharma, and has become a key venue for showcasing major breakthroughs in computational drug discovery.

Venue & Location

Boston Marriott Copley Place, located in the heart of Boston, a major global hub for biotechnology and pharmaceutical innovation.

Related Conference Categories

This conference covers topics in the following pharma and life sciences domains. Explore more events in each category using our conference directory filters.

AI & DataAI & Machine Learning in Pharma

Resources & Links

About AI Drug Discovery & Development Summit (Kisaco Research)

AI Drug Discovery & Development Summit (Kisaco Research) is a in-person event scheduled for 2026-10-27 to 2026-10-29 in Boston Marriott Copley Place, Boston, MA. The conference focuses on ai in drug discovery and development (leading global event). This event is categorized under AI & Machine Learning in Pharma in our conference directory.

The AI Drug Discovery & Development Summit, organized by Kisaco Research, is a premier annual event focused on the integration of artificial intelligence and machine learning into the pharmaceutical R&D pipeline. It brings together global leaders to explore how AI can accelerate target identification, optimize lead discovery, and streamline clinical development. The summit is highly regarded for its focus on practical, actionable insights, bridging the gap between cutting-edge computational research and real-world drug development outcomes. This event stands out for its emphasis on cross-functional collaboration, bringing together data scientists, biologists, and clinical researchers. Attendees gain access to case studies from major pharma and innovative biotech firms, highlighting both the successes and the technical challenges of implementing AI. It is a critical forum for shaping the future of digital transformation in the life sciences sector.

Professionals attending conferences like AI Drug Discovery & Development Summit (Kisaco Research) gain access to cutting-edge insights, peer networking, and exposure to the latest technologies shaping the pharmaceutical and biotechnology sectors. Whether you are evaluating new vendors, seeking regulatory updates, or expanding your professional network, industry conferences remain one of the most effective ways to stay current in life sciences.

AI and machine learning continue to transform the pharmaceutical industry, from drug discovery to commercial operations. Conferences featuring AI content provide valuable exposure to real-world implementations and emerging capabilities. Explore our Pharmaceutical GenAI Tracker for a comprehensive view of AI deployments across the industry.

Looking for guidance on which conferences to attend or how to build your event strategy for 2026? Book a meeting with the IntuitionLabs team to discuss your priorities and how we can support your team.

© 2026 IntuitionLabs. All rights reserved.